Literature DB >> 23257726

[Inhibition of Candida mycelia growth by a medium chain fatty acids, capric acid in vitro and its therapeutic efficacy in murine oral candidiasis].

Miki Takahashi1, Shigeharu Inoue, Kazumi Hayama, Kentaro Ninomiya, Shigeru Abe.   

Abstract

We assessed anti-C. albicans activities of the 4 fatty acids : caproic acid, caprylic acid, capric acid and lauric acid in vitro. All four inhibited not only the mycelial but also the yeast-form growth of Candida albicans. In particular, capric acid and caprylic acid inhibited Candida mycelia growth at very low concentrations. The effects of treatment of these two fatty acids on oral candidiasis were examined using a murine model. When 50 µl of capric acid (more than 48.8 µM) was administered three times into the oral cavity of Candida-infected mice, symptom scores of tongues of the mice were significantly improved. Histological studies of the capric acid-treated animals indicated that the fatty acid suppressed mycelial growth of the fungus on the tongue surface. These results suggest that all four fatty acids, and especially capric acid, have potential as substances supporting anti-Candida treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23257726     DOI: 10.3314/mmj.53.255

Source DB:  PubMed          Journal:  Med Mycol J


  2 in total

1.  Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition.

Authors:  Hubertine M E Willems; Jeremy S Stultz; Molly E Coltrane; Jabez P Fortwendel; Brian M Peters
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 2.  The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis.

Authors:  Silke Baldewijns; Mart Sillen; Ilse Palmans; Paul Vandecruys; Patrick Van Dijck; Liesbeth Demuyser
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.